Virtual Reality for Procedural Pain During IV Cannulation in Children
VR-PED
The Impact of Virtual Reality Distraction on Procedural Pain, Duration, and Parental Satisfaction During Intravenous Cannulation and Blood Sampling in the Pediatric Emergency Department: A Prospective Quasi-Experimental Study
2 other identifiers
interventional
150
1 country
1
Brief Summary
This study evaluates whether virtual reality (VR)-based distraction can reduce pain during intravenous cannulation and venous blood sampling in children treated in a pediatric emergency department. Children aged 6-11 years who required these procedures received either standard care or VR distraction using age-appropriate audiovisual content. The primary outcome was procedure-related pain measured by the Wong-Baker FACES Pain Rating Scale. Secondary outcomes included procedural duration, cooperation, first-attempt success, behavioral distress, and parental satisfaction. The study also explored whether the effectiveness of VR was associated with patient engagement during the procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 13, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 22, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 22, 2026
CompletedFirst Submitted
Initial submission to the registry
May 21, 2026
CompletedFirst Posted
Study publicly available on registry
August 3, 2026
CompletedAugust 3, 2026
May 1, 2026
1.4 years
May 21, 2026
July 31, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Procedure-related pain
Procedure-related pain assessed using the Wong-Baker FACES Pain Rating Scale (WBFPS) following intravenous cannulation or venous blood sampling.
Immediately after the procedure
Study Arms (1)
Virtual Reality Group
EXPERIMENTALChildren received age-appropriate audiovisual distraction through a virtual reality headset during intravenous cannulation or venous blood sampling procedures.
Interventions
Participants received age-appropriate audiovisual distraction through a virtual reality headset (Meta Quest 3S) during intravenous cannulation or venous blood sampling. The intervention aimed to reduce procedural pain and distress by redirecting attention away from the procedure toward immersive VR content.
Eligibility Criteria
You may qualify if:
- Children aged 6-11 years
- Requirement for intravenous cannulation or venous blood sampling in the -pediatric emergency department
- Ability to understand and engage with virtual reality content
- Written informed consent obtained from parent or legal guardian
You may not qualify if:
- Visual or hearing impairment preventing VR use
- Neurological or developmental disorders affecting communication or cooperation
- Altered level of consciousness
- Hemodynamic instability requiring immediate intervention
- Previous participation in the study
- Refusal of participation by the child or parent/legal guardian
- Contraindications to virtual reality exposure (e.g., severe motion sickness or intolerance)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ege Universitylead
Study Sites (1)
Ege University
Izmir, 35100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Pediatric Emergency Medicine Specialist
Study Record Dates
First Submitted
May 21, 2026
First Posted
August 3, 2026
Study Start
September 13, 2024
Primary Completion
January 22, 2026
Study Completion
January 22, 2026
Last Updated
August 3, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be publicly shared because the study includes pediatric participants, and data sharing may increase the risk of participant re-identification. De-identified data may be made available upon reasonable request to the corresponding author, subject to institutional ethics approval and applicable regulations.